Super-mini percutaneous nephrolithotomy versus flexible ureteroscopy for renal stones ≤20 mm: A single-center randomized controlled trial with cost analysis and safety outcomes
Urology Annals · 2026-10 · 18 (4) · 322-327
DOI: 10.4103/ua.ua_25_26 ↗Abstract
Abstract Context: Super-mini percutaneous nephrolithotomy (SMP) and flexible ureteroscopy (fURS) are minimally invasive for small renal stones, but comparative data on safety and cost in resource-limited settings are scarce. Aims: The aim of this study was to compare the efficacy, safety, and cost of SMP and fURS for renal stones ≤20 mm. Settings and Design: This was a single-center, open-label randomized controlled trial at a tertiary-care hospital in Vietnam (2024). Materials and Methods: Patients were randomized to SMP or fURS. The primary outcome was the stone-free rate (SFR) at 1 month, assessed by an independent blinded radiologist. The secondary outcomes included operative time, hemoglobin drop, hospital stay, complications, and total cost. Analysis was performed on an intention-to-treat basis. This trial is reported in accordance with the CONSORT 2025 statement (Supplementary File 1). Statistical Analysis Used: Continuous variables were compared using Student’s t -test or Mann–Whitney U test. Categorical variables were analyzed using Chi-square or Fisher’s exact tests where appropriate. P
EUVIMED